Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.

NCT00267358 is registered in ClinicalTrials.gov with Helsinn Therapeutics (U.S.), Inc as lead sponsor.

NCT NCT00267358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00267358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
Lead sponsor
Helsinn Therapeutics (U.S.), Inc
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2005
Completion date
October 31, 2006
Enrollment
Not reported
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

cancer cachexia